跳至主要内容
临床试验/NL-OMON45108
NL-OMON45108已完成3 期

A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis combined with standard anticoagulant therapy versus standard anticoagulant therapy alone for acute primary iliofemoral deep vein thrombosis (IFDVT). - CDT or conventional anticoagulant therapy in DVT.

academisch ziekenhuis Maastricht0 个研究点目标入组 184 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age between 18-85 yrs, objectively documented IFDVT at least no patency in the common femoral vein, acute stage ( 6 months, first thrombus in the affected leg,

排除标准

  • History of GI bleeding within 12 months, History of CVA/CNS disease whitin 12 months, Severe hypertension ( >180/100 mmHg), Active malignancy, Major surgery within 6 weeks, Previous thrombosis of the affected limb, Varicositas/venous insufficiency, (CEAP classification C3 or higher) Pregnancy, ALAT > 3 times normal range, GFR < 30 mL/min ,
  • permanent wheelchair dependency

研究者

相似试验